Hostname: page-component-78c5997874-lj6df Total loading time: 0 Render date: 2024-11-19T06:48:12.769Z Has data issue: false hasContentIssue false
  • English
  • Français

First Onset of Schizophrenia

Published online by Cambridge University Press:  07 November 2014

David L. Dunner
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Interactive Case Conference
Information
CNS Spectrums , Volume 11 , Issue 1 , January 2006 , pp. 19
Copyright
Copyright © Cambridge University Press 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Disclosure: Dr. Dunner is a consultant to Bristol-Myers Squibb, Corcept, Cypress, Eli Lilly, GlaxoSmithKline, Janssen, Novartis, Otsuka, Pfizer, Shire, Somerset, and Wyeth; is on the speakers bureaus of Bristol-Myers Squibb, Eli Lilly, Forest, GlaxoSmithKline, Organon, Pfizer, and Wyeth.

Funding/Support: Dr. Dunner has received grant support from Cyberonics, Eli Lilly, GlaxoSmithKline, Janssen, Merck, Pfizer, and Wyeth.